Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Culakova

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|May 18, 2006
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapyMichelle Shayne, Jeffrey Crawford, David C Dale, et al.
Journal of Cancer Survivorship : Research and Practice|December 6, 2013
The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residentsMichelle Shayne, Eva Culakova, Michael T Milano, et al.
Journal of Hematology & Oncology|August 21, 2010
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy deliveryMatthias Schwenkglenks, Ruth Pettengell, Thomas D Szucs, et al.
Journal of the American Geriatrics Society|January 31, 2025
Response to: "Enhancing Geriatric Assessment in Cancer Rehabilitation: Suggestions for Future Research"Supriya Mohile, Rachelle Brick, Marielle Jensen-Battaglia, et al.
Cancer|October 6, 2007
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patientsAlok A Khorana, Charles W Francis, Eva Culakova, et al.
Blood|January 25, 2008
Development and validation of a predictive model for chemotherapy-associated thrombosisAlok A Khorana, Nicole M Kuderer, Eva Culakova, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trialsGina L Mazza, Eva Culakova, Danielle M Enserro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Understanding Treatment Tolerability in Older Adults With CancerMarie A Flannery, Eva Culakova, Beverly E Canin, et al.
The Oncologist|April 30, 2016
A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and MortalityNicole M Kuderer, Eva Culakova, Gary H Lyman, et al.
Clinical Lung Cancer|December 14, 2017
Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With NeutropeniaJulia Cupp, Eva Culakova, Marek S Poniewierski, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|May 18, 2006
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapyMichelle Shayne, Jeffrey Crawford, David C Dale, et al.
Journal of Cancer Survivorship : Research and Practice|December 6, 2013
The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residentsMichelle Shayne, Eva Culakova, Michael T Milano, et al.
Journal of Hematology & Oncology|August 21, 2010
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy deliveryMatthias Schwenkglenks, Ruth Pettengell, Thomas D Szucs, et al.
Journal of the American Geriatrics Society|January 31, 2025
Response to: "Enhancing Geriatric Assessment in Cancer Rehabilitation: Suggestions for Future Research"Supriya Mohile, Rachelle Brick, Marielle Jensen-Battaglia, et al.
Cancer|October 6, 2007
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patientsAlok A Khorana, Charles W Francis, Eva Culakova, et al.
Blood|January 25, 2008
Development and validation of a predictive model for chemotherapy-associated thrombosisAlok A Khorana, Nicole M Kuderer, Eva Culakova, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trialsGina L Mazza, Eva Culakova, Danielle M Enserro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Understanding Treatment Tolerability in Older Adults With CancerMarie A Flannery, Eva Culakova, Beverly E Canin, et al.
The Oncologist|April 30, 2016
A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and MortalityNicole M Kuderer, Eva Culakova, Gary H Lyman, et al.
Clinical Lung Cancer|December 14, 2017
Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With NeutropeniaJulia Cupp, Eva Culakova, Marek S Poniewierski, et al.
Pageof 14